Clinikk

Clinikk, operated by Ohealer Healthcare Services Private Limited, is a Bengaluru-based primary healthcare provider that combines outpatient care delivery with financial protection against medical costs. Members pay a monthly or annual subscription (starting at ₹900 per month as advertised on the company's site) that covers unlimited general-physician consultations at its physical clinics, called Health Hubs, or through a 24/7 online clinic, plus doctor-prescribed medicines and laboratory tests at no additional cost, reimbursement of bills from specialists consulted elsewhere, and referral guidance.

Alongside the care membership, Clinikk offers an optional group health insurance add-on underwritten by IndusInd General Insurance, an IRDAI-registered insurer, providing cashless hospitalisation at a stated network of 10,000 hospitals, covers of up to ₹55 lakh with accidental cover up to ₹5 lakh, and maternity, private-room, ambulance and Section 80D tax benefits. The company states it is a primary care provider rather than an insurer. Its consumer-facing clinic proposition emphasises short waiting times, avoidance of unnecessary tests and treatments, and clear next steps, with clinic services covering GP consultations, chronic-condition medicines (blood pressure, diabetes, cholesterol), blood tests (liver, kidney, diabetes), ECG and specialist referrals. Earlier coverage described the offering as an app-based service for blue-collar and lower-middle-income workers, with plans priced from ₹100 to ₹500 per month, a network of more than 100 general practitioners and specialists, multilingual health assistants covering 11 languages, and family health profiles maintained for continuity of care.

Founding story

Co-founders Bhavjot Kaur and Dr. Suraj Baliga met in Bengaluru in 2014 while both were involved in an election campaign. Kaur, a Geological Technology graduate of IIT Roorkee who worked for four years as a geoscientist at Royal Dutch Shell, lost her father to complications of diabetes and hypertension that progressed to renal failure; the family travelled from Assam to Chennai for treatment and, without health insurance, exhausted its savings. Baliga, an orthopaedic surgeon who completed his MBBS at Kasturba Medical College, Manipal and postgraduate training at Bangalore Medical College, saw in clinical practice that lower-middle-income patients struggled to obtain quality primary care and that many hospitalisations could have been avoided with better care at home. These experiences led them to build a service intended to be a family's first point of contact for illness without financial strain.

Business model

Subscription memberships sold to individuals and families, and to employers for their workforces, covering unlimited outpatient consultations, prescribed medicines and diagnostics, with an optional insurance add-on distributed in partnership with a licensed insurer. Care is delivered through owned neighbourhood Health Hubs and a 24/7 teleconsultation service via the Clinikk app.

Recurring monthly or annual membership fees (advertised from ₹900 per month on the company site; historically ₹100-₹500 per month plans, including a ₹500 per month all-inclusive plan launched in August 2022), with additional revenue from corporate health plans and insurance add-ons. Inc42 reports revenue of ₹8.5 crore in FY25, up 44.2% from ₹5.9 crore in FY24.

Traction

The company's site reports 4,10,000+ lives touched, 1,50,000+ consultations completed, ₹17 crore in expenses saved, more than 20,000 five-star ratings, 12 Health Hubs in Bengaluru and more than 300 companies as customers or partners. In November 2021 it reported over 10,000 family subscriptions on its full-stack plan growing 30% month-on-month, and in December 2019 press reported about 200,000 subscribers. Inc42 lists 203 employees and FY25 revenue of ₹8.5 crore.

Latest developments

The company operates 12 Health Hubs in Bengaluru and markets memberships from ₹900 per month with an optional IndusInd General Insurance group health cover. Inc42 records a most recent funding round dated 3-4 December 2024 and total funding of $9.42 million across five rounds, with FY25 revenue of ₹8.5 crore.